FLORENCE, Ky., April 26, 2006 (PRIMEZONE) -- ImmuDyne (Pink Sheets:IMMD), the leading Yeast Beta Glucan Company, today announced fiscal 2005 audited financial results.
In the latest fiscal year, ImmuDyne earned slightly more than $0.01 (one cent) per share, had positive net cash provided by operating activities of $342,313, while generating revenues of $2,882,126.
The Company auditor, PKF, verified that there were no ongoing concern uncertainties. Moreover, PKF confirmed that ImmuDyne's cash and restricted cash grew to approximately $780,000 at fiscal year end. Management believes that this cash position is more than adequate to meet any of ImmuDyne's obligations for the foreseeable future.
ImmuDyne has approximately nineteen million shares outstanding.
About ImmuDyne
ImmuDyne shares trade under the ticker symbol IMMD (PK) and the Company can be found on the web at www.immudyne.com.
This press release may include statements that constitute "forward looking statements," within the meaning of Securities Act of 1933 and the Securities Act of 1934. All statements, other than statements of historical facts, that address activities, events or developments that the Company expects, believes or anticipates are forward looking statements. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward looking statements.